Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Clinical Trial

Official title:

Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05200585
• Other study ID #: HSC-SPH-21-1008
• Status: Completed
• Phase: N/A
• Start date: May 11, 2022
• Est. completion date: July 20, 2023

Study information

• Verified date: October 2023
• Source: The University of Texas Health Science Center, Houston
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to pilot test a behavioral lifestyle intervention for Hispanic/Latino patients with non-alcoholic fatty liver disease (NAFLD)

Recruitment information / eligibility

• Status: Completed
• Enrollment: 27
• Est. completion date: July 20, 2023
• Est. primary completion date: July 20, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Self-reported Hispanic/Latino
• Have been diagnosed with NAFLD
• Able to speak English or Spanish
• Have access to internet, either on their phone, at home or at some other location convenient to the participant

Exclusion Criteria:

• Does not have a working telephone number

Related Conditions & MeSH terms

• Fatty Liver
• Liver Diseases
• Non-Alcoholic Fatty Liver Disease

Intervention

Behavioral:
• Healthy Liver/Hígado Sano program
The program will last 4-6 months and include 16 sessions, each 30-60 minutes long, that focus on self-management strategies for dietary changes and physical activity and is meant to be delivered in 4-6 months. The 16 sessions are as follows: 1) Introduction to the program, 2) Get Active, 3) Track Your Activity, 4) Eat Well, 5) Track Your Food, 6) Get More Active, 7) Burn More Calories Than You Take In, 8) Shop and Cook, 9) Manage Stress, 10) Find Time for Fitness, 11) Cope with Triggers, 12) Keep Your Heart Healthy, 13) Take Charge of Your Thoughts, 14) Get Support, 15) Eat Well Away from Home, and 16) Staying Motivated
• Usual standard of care
Participants will receive ongoing monitoring of condition at the clinic per standard of care and a short informational pamphlet

Locations

Country	Name	City	State
United States	The University of Texas Health Science Center at Houston	Houston	Texas

Sponsors (2)

Lead Sponsor	Collaborator
The University of Texas Health Science Center, Houston	Prevent Cancer Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of participants recruited		end of study(6 months after enrollment)
Primary	Number of participants that adhere to the intervention		end of study(6 months after enrollment)
Primary	Number of participants that complete the study		end of study(6 months after enrollment)
Primary	Intervention group participants Satisfaction of program as assessed by the Client Satisfaction Questionnaire (CSQ-8)	The Client Satisfaction Questionnaire (CSQ) has 8 items.Each one is scored from 1-4, with a total possible score of 32, a higher score indicating greater satisfaction	end of study(6 months after enrollment)
Secondary	Height of participants		Baseline, 6 months after enrollment
Secondary	Change in weight of participants		Baseline, 6 months after enrollment
Secondary	Change in liver function as assessed by alanine aminotransferase (ALT) levels	Higher levels of ALT indicates liver damage	Baseline, 6 months after enrollment
Secondary	Change in liver function as assessed by the Fibrosis-4 (FIB-4) index	The FIB-4 score consists of 4 variables including age,aspartate aminotransferase(AST), ALT, and platelets and evaluates the degree of fibrosis for patients suspected of or already diagnosed with hepatic fibrosis. Participants at low risk of advanced fibrosis have an index of less than 1.3 (age <65 years) or less than 2.0 (age =65 years); a score greater than 3.25 is suggestive of advanced fibrosis	Baseline, 6 months after enrollment
Secondary	Change in physical activity as assessed by the Actigraph GT9X accelerometers	Moderate-vigorous physical activity counts during the 7-day period will be calculated by summing moderate and vigorous activity counts and then applying a logarithmic transformation to address skew.	Baseline, 6 months after enrollment
Secondary	Change in physical activity as assessed by the International Physical Activity Questionnaire	This is a 27-item self-reported measure of physical activity. The result is reported categorically in one of three categories as follows: Low/inactive - do not meet the criteria for moderate or high activity levels, Moderate - meet 1 of the following: A) 3 or more days with at least 30 minutes of moderate-intensity activity or walking; B) 5 or more days with at least 30 minutes of moderate-intensity activity or walking; C) 5 or more days of any combination of walking, moderate-intensity, or vigorous intensity activities with at least 600 metabolic equivalent of task (MET)-minutes per week. [One MET is energy expenditure when at rest. For instance, 2 METs is twice the energy expended while at rest.] and high - meet 1 of the following: A: 3 or more days of vigorous-intensity activity and at least 1500 MET-minutes per week; B) 7 days of any combination of walking, moderate-intensity or vigorous intensity activities with at least 3000 MET-minutes per week.	Baseline, 6 months after enrollment
Secondary	Change in diet as assessed by the School Physical Activity & Nutrition (SPAN) survey - Healthy foods index	The School Physical Activity and Nutrition (SPAN) questionnaire is a brief self-administered measure of dietary intake. The healthy foods index will be reported, and total score ranges from 0-50, with a higher score indicating more frequent intake of healthy foods.	Baseline, 6 months after enrollment
Secondary	Change in diet as assessed by the School Physical Activity & Nutrition (SPAN) survey - Unhealthy foods index	The School Physical Activity and Nutrition (SPAN) questionnaire is a brief self-administered measure of dietary intake. The unhealthy foods index will be reported, and total score ranges from 0-45, with a higher score indicating more frequent intake of unhealthy foods.	Baseline, 6 months after enrollment
Secondary	Change in alcohol use as assessed by the alcohol use disorders identification test (AUDITC)	alcohol use disorders identification test (AUDITC) is a 3 item measure and will give a general idea of how often participants are drinking alcohol and in what quantities	Baseline, 6 months after enrollment
Secondary	Change in social support for physical activity as assessed by the Social Support for Exercise scales	This scale has 13 items, each is scored from 1(none)-5(very often) and 8(does not apply), higher number indicating better social support	Baseline, 6 months after enrollment
Secondary	Change in social support for diet as assessed by the Social Support for Diet scales	This scale has 10 items each is scored from 1(none)-5(very often) and 8(does not apply)	Baseline, 6 months after enrollment
Secondary	Change in participant illness perception as assessed by the brief Illness Perception Questionnaire	This is a 9 item questionnaire. The first 8 questions are scored from 0-10 and the 9th question will ask the subject to list in rank-order the three most important factors that they believe caused their illness.	Baseline, 6 months after enrollment
Secondary	Change in perceived severity	Perceived severity will be measured with 2 adapted items that assess to what extent they believe fatty liver disease is a severe health problem and to what extent do they consider complications for fatty liver to be severe health problems. Participants respond on a scale of 1-5, with a higher number indicating a perception that NAFLD is extremely severe.	Baseline, 6 months after enrollment
Secondary	Change in Perceived treatment efficacy	Perceived treatment efficacy will be assessed with 8 items, also adapted from Glasgow et al.that assess the importance of four protective factors (weight loss, eating healthy, avoiding sweets, and physical activity) and the likeliness of those factors to prevent future complications from fatty liver disease. Participants respond on a scale of 1-5, with a higher number indicating higher confidence in NAFLD treatment .	Baseline, 6 months after enrollment
Secondary	Change in Stress as assessed by the 4 items Perceived Stress Scale	Each of the 4 items is scored form (never)-4(very often) with a highest score of 16,indicating more stress	Baseline, 6 months after enrollment
Secondary	Change in Depression as assessed by the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10)	This scale consists of 10 questions each one is scored form rarely or none of the time to all of the time.The total score is calculated by finding the sum of 10 items. Any score equal to or above 10 is considered depressed.	Baseline, 6 months after enrollment
Secondary	Change in Anxiety as assessed by the 7-item Generalized Anxiety Disorder (GAD-7) questionnaire.	This scale consists of 7 questions and each is scored form 0(not at all) to 3(nearly every day) for a maximum score of 21, a higher score indicating more anxiety	Baseline, 6 months after enrollment